Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ACROSTART: A retrospective study of the time to achieve hormonal control with lanreotide Autogel treatment in Spanish patients with acromegaly.
Álvarez-Escolá C, Venegas-Moreno EM, García-Arnés JA, Blanco-Carrera C, Marazuela-Azpiroz M, Gálvez-Moreno MÁ, Menéndez-Torre E, Aller-Pardo J, Salinas-Vert I, Resmini E, Torres-Vela EM, Gonzalo-Redondo MÁ, Vílchez-Joya R, de Miguel-Novoa MP, Halperín-Rabinovich I, Páramo-Fernández C, de la Cruz-Sugranyes G, Houchard A, Picó-Alfonso AM; ACROSTART Study Group. Álvarez-Escolá C, et al. Among authors: houchard a. Endocrinol Diabetes Nutr (Engl Ed). 2019 May;66(5):320-329. doi: 10.1016/j.endinu.2018.12.004. Epub 2019 Feb 14. Endocrinol Diabetes Nutr (Engl Ed). 2019. PMID: 30773338 Free article. English, Spanish.
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Acromegaly in Routine Clinical Practice in Germany, Austria and Switzerland.
Störmann S, Schopohl J, Bullmann C, Terkamp C, Christ-Crain M, Finke R, Flitsch J, Kreitschmann-Andermahr I, Luger A, Stalla G, Houchard A, Helbig D, Petersenn S. Störmann S, et al. Among authors: houchard a. Exp Clin Endocrinol Diabetes. 2021 Mar;129(3):224-233. doi: 10.1055/a-1247-4713. Epub 2020 Dec 7. Exp Clin Endocrinol Diabetes. 2021. PMID: 33285601 Free article.
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and Austria.
Rinke A, Maintz C, Müller L, Weber MM, Lahner H, Pavel M, Saeger W, Houchard A, Ungewiss H, Petersenn S. Rinke A, et al. Among authors: houchard a. Exp Clin Endocrinol Diabetes. 2021 Jul;129(7):500-509. doi: 10.1055/a-1342-2755. Epub 2021 Jul 22. Exp Clin Endocrinol Diabetes. 2021. PMID: 34293802 Free PMC article. Clinical Trial.
Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results.
Pavel M, Ćwikła JB, Lombard-Bohas C, Borbath I, Shah T, Pape UF, Capdevila J, Panzuto F, Truong Thanh XM, Houchard A, Ruszniewski P. Pavel M, et al. Among authors: houchard a. Eur J Cancer. 2021 Nov;157:403-414. doi: 10.1016/j.ejca.2021.06.056. Epub 2021 Sep 28. Eur J Cancer. 2021. PMID: 34597974 Free article. Clinical Trial.
40 results